EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study

Oluwatobiloba Ayo-Ajibola iD, Milan P Fehrenbach iD, Asher C Park iD, Jonathan D West iD, Daniel I Kwon iD

Head & Neck · 2025

DOI: 10.1002/hed.28232 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Head & Neck, 2025. Verfasst von Oluwatobiloba Ayo-Ajibola und 4 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine of the University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Thyroidectomy, Analgesics, Opioid, Postoperative Pain, Opioid-Related Disorders. Die Arbeit nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluates the risk of persistent opioid use (POU) among thyroidectomy patients given postoperative opioids.

Methods

Patients undergoing thyroidectomy were identified using the TriNetX Research Platform (2010–2024). Cohorts were divided based on opioid prescriptions on the day of surgery. With propensity score matching to prevent confounding bias, risk ratios were calculated for opioid prescriptions 3–9 months post‐surgery. Secondary outcomes included ED presentation, pain diagnosis, and lifetime risk of opioid use disorder, defined as significant social dysfunction due to uncontrolled use.

Results

The post‐match opioid group ( n = 19,727) experienced a 4.61% risk of POU (control: 4.07%), representing a 14% higher risk of POU compared to the non‐opioid group (RR 1.14, 95% CI: [1.03, 1.25]). Opioids slightly decreased the likelihood of outpatient visits at 30 days (RR: 0.97 [0.95, 0.98]) and 90 days (RR: 0.96 [0.94, 0.97]) following surgery. There were no significant differences in ED presentation, pain diagnoses at 30 and 90 days, or lifetime OUD risk.

Conclusion

Post‐thyroidectomy opioid prescription modestly increases POU risk, highlighting the need for careful patient counseling and judicious use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroidectomyAnalgesics, OpioidPostoperative PainOpioid-Related DisordersHumansFemaleMalePropensity ScoreMiddle AgedAdultRetrospective StudiesDrug PrescriptionsCohort StudiesAgedRisk Assessment

Stichwörter der Autor:innen

endocrine surgical proceduresopioidsopioid‐related disorderspostoperative painthyroidectomy

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • University of Kentucky College of Medicine, Lexington, Kentucky, USA.
  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Caruso Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Oluwatobiloba Ayo-Ajibola, Milan P Fehrenbach, Asher C Park, Jonathan D West, Daniel I Kwon

Zitieren

APA

Ayo-Ajibola, O., Fehrenbach, M. P., Park, A. C., West, J. D., & Kwon, D. I. (2025). Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study. Head & Neck. https://doi.org/10.1002/hed.28232

Vancouver

Ayo-Ajibola O, Fehrenbach MP, Park AC, West JD, Kwon DI. Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study. Head & Neck. 2025. doi:10.1002/hed.28232

BibTeX
@article{AyoAjibola2025,
  author = {Ayo-Ajibola, Oluwatobiloba and Fehrenbach, Milan P and Park, Asher C and West, Jonathan D and Kwon, Daniel I},
  title = {Post‐Thyroidectomy Opioid Prescription and Risk of Persistent Opioid Use: A Propensity Matched Cohort Study},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.28232}
}
Kostenlos starten →